At a glance
The April 6, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on serology tests, answers to submitted questions, CLIA guidance, hospital systems during the COVID-19 response, Nebraska's public health laboratory response, reporting testing data to ÐÇ¿ÕÓéÀÖ¹ÙÍø, and biosafety.
Agenda
Welcome and Introductions: Jasmine Chaitram, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems
Performance Evaluation of Commercially Developed Serology Tests: Michele Owen, ÐÇ¿ÕÓéÀÖ¹ÙÍø Laboratory Task Force
Updates and Responses to Submitted Questions on Diagnostics and Testing: Tim Stenzel, U.S. Food and Drug Administration (FDA)
Additional CLIA Guidance for Testing Laboratories: Karen Dyer, Centers for Medicare & Medicaid Services (CMS)
COVID-19 Response – Hospital System on the Front Lines: James (Jim) Crawford, Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellHealth, Lake Success, New York
Nebraska's Public Health Laboratory Response: Peter Iwen, Nebraska State Public Health Laboratory
Reporting Testing Data to ÐÇ¿ÕÓéÀÖ¹ÙÍø: Jasmine Chaitram, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems
Laboratory Biosafety Update for COVID-19: Bill Arndt, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems